{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026632","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.904269+00:00","generated_at":"2026-06-21T03:50:32.053715+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pediatrix appoints Dr. James Swift as CEO; Mark Ordan becomes Executive Chair","bullets":["James D. Swift, M.D., named CEO effective Jan 1, 2023; succeeds Mark S. Ordan.","Mark Ordan appointed Executive Chair of the Board; Guy Sansone becomes Lead Independent Director.","Swift's base salary increased to $650,000; annual bonus opportunity set at 125% of base.","Ordan to receive $60,000 monthly fee as Executive Chair through June 30, 2023.","Swift, a physician and former COO, joined Pediatrix in 2009 through an acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026632","json":"https://secwatch.observer/filing/0000950170-22-026632.json","markdown":"https://secwatch.observer/filing/0000950170-22-026632.md","text":"https://secwatch.observer/filing/0000950170-22-026632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/md-20221215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:50:32.053715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2cdc41029b","claim":"Mark S. Ordan was appointed as Executive Chair of the Board at Pediatrix Medical Group, Inc..","evidence_excerpt":"Mr. Mark S. Ordan, who has been appointed as the Executive Chair of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chair of the Board"}],"fact_type":"executive_change"},{"claim_id":"a27efdfa80","claim":"James D. Swift, M.D. was appointed as Chief Executive Officer at Pediatrix Medical Group, Inc..","evidence_excerpt":"appointed James D. Swift, M.D., as the Company’s Chief Executive Officer and principal executive officer to succeed Mr. Mark S. Ordan","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}